Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
Jump to:
| Preferred Name | Linagliptin [Chemical/Ingredient] | |
| Synonyms |
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Linagliptin |
|
| ID |
http://purl.bioontology.org/ontology/NDFRT/N0000191976 |
|
| altLabel |
1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)- (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione Linagliptin
|
|
| cui |
C2746078
|
|
| MESH DEFINITION |
A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
|
|
| MESH DUI |
D000069476
|
|
| MeSH name |
Linagliptin
|
|
| MESH UI |
M0554626
|
|
| NDFRT kind |
INGREDIENT_KIND
|
|
| notation |
N0000191976
|
|
| NUI |
N0000191976
|
|
| prefLabel |
Linagliptin [Chemical/Ingredient]
|
|
| tui |
T109 T121
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping